Back to Ticker
Jenburkt Pharmaceuticals Limited
NSE: JENBURPH₹920.95
-0.27%EOD · 19 OctMarket Cap
—
52W Range
₹1074 / ₹864
Volume
1K
75.5% delivery
1Y Return
—
P/E Ratio
12.4
P/B Ratio
2.1
Debt / Equity
1.26
Quality Score
Durability · Valuation · Momentum — objective math, not adviceB
66/100
Composite score: 40% quality, 30% valuation, 30% momentum
QualityAverage · 50
ValuationStrong · 88
MomentumGood · 65
Inexpensive valuation (P/E 12x)
Technical Indicators
46d data — partial · objective math, not adviceReturns
1D
-0.3%
1W
-0.4%
1M
-6.0%
3M
—
6M
—
1Y
—
RSI (14)
49 Neutral
Moving Averages (price vs MA)
20-DMA
₹926
below
50-DMA
—
150-DMA
—
200-DMA
—
From 52W High
-14.2%
From 52W Low
+6.6%
Support (20D)
₹864
Resistance (20D)
₹1052
Technical indicators are objective calculations from historical EOD prices (RSI, moving averages, Weinstein stage, Minervini trend-template, relative strength). For educational reference only — not a buy/sell recommendation.
News & FilingsGoogle News + BSE
Jenburkt Pharmaceuticals Ltd. (NSE: JENBURPH) Business Overview and Growth Factors
Kalkine India· 11 SeptANUHPHR Stock Price and Chart — NSE:ANUHPHR
TradingView· 20 DecYes Bank Share Pros and Cons: Turnaround or Trap 2026
Univest· 5 AugSGRL Stock Price and Chart — NSE:SGRL
TradingView· 17 AugWANBURY Stock Price and Chart — NSE:WANBURY
TradingView· 13 Aug
News via Google News · Not verified by IPOpulse · Not investment advice
Community discussion(0)
Sign in to join the discussion.
Sign inNo comments yet — be the first to share your view.